Multi-Country analysis of treatment costs for HIV/AIDS (match): Facility-level art unit cost analysis in Ethiopia, Malawi, Rwanda, South Africa and Zambia
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ARTICLE;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
ETHIOPIA;
HEALTH CARE AVAILABILITY;
HEALTH CARE COST;
HEALTH CARE FACILITY;
HEALTH CARE PLANNING;
HEALTH CARE UTILIZATION;
HEALTH SERVICE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MALAWI;
OUTCOME ASSESSMENT;
PATIENT CARE;
PRACTICE GUIDELINE;
RETROSPECTIVE STUDY;
RWANDA;
SOUTH AFRICA;
TREATMENT OUTCOME;
ZAMBIA;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
CD4+ T LYMPHOCYTE;
COMMUNICABLE DISEASE;
COMPARATIVE STUDY;
CYTOLOGY;
DEVELOPING COUNTRY;
ECONOMICS;
HEALTH CARE DELIVERY;
HIV INFECTIONS;
INFECTION CONTROL;
STATISTICAL MODEL;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ANTI-RETROVIRAL AGENTS;
CD4-POSITIVE T-LYMPHOCYTES;
COMMUNICABLE DISEASE CONTROL;
COMMUNICABLE DISEASES;
DEVELOPING COUNTRIES;
ETHIOPIA;
HEALTH CARE COSTS;
HEALTH SERVICES ACCESSIBILITY;
HEALTH SERVICES NEEDS AND DEMAND;
HIV INFECTIONS;
HUMANS;
MALAWI;
MODELS, ECONOMIC;
RWANDA;
SOUTH AFRICA;
TREATMENT OUTCOME;
ZAMBIA;
Antiretroviral medicines in low- and middle-income countries
WHO ISBN 978-92- 4150-546-8
WHO (2013) Antiretroviral Medicines in Low- and Middle- Income Countries: Forecasts of Global and Regional Demand for 2012-2015. WHO. ISBN 978-92- 4150-546-8.
The cost of providing comprehensive HIV treatment in PEPFAR-supported programs
Menzies NA, Cohen T, Lin H-H, Murray M, Salomon JA, et al. (2011) The cost of providing comprehensive HIV treatment in PEPFAR-supported programs. AIDS 25(14): 1753-1760. doi: 10.1097/QAD.0b013e3283463eec.
How much does it cost to provide antiretroviral therapy for HIV/AIDS in Africa?
Center for International Health and Development, Boston University School of Public Health Accessed 2014 Oct 25
Rosen S Long L (2006) How much does it cost to provide antiretroviral therapy for HIV/AIDS in Africa? Health and Development Discussion Paper No. 9. Center for International Health and Development, Boston University School of Public Health. 1-11 p. Available: https://www.bu.edu/av/iaen/research-library- 1/docs/13387/Rosen%20Cost%20of%20ART%20in%20Africa.pdf. Accessed 2014 Oct 25.
Taking ART to scale: Determinants of the cost and cost-effectiveness of antiretroviral therapy in 45 clinical sites in zambia
Marseille E, Giganti MJ, Mwango A, Chisembele-Taylor A, Mulenga L, et al. (2012) Taking ART to Scale: Determinants of the Cost and Cost-Effectiveness of Antiretroviral Therapy in 45 Clinical Sites in Zambia. PLoS ONE 7(12): e51993. doi: 10.1371/journal.pone.0051993.
Unit costs for delivery of antiretroviral treatment and prevention of mother-to-child transmission of HIV: A systematic review for low- and middle-income countries
Galárraga O, Wirtz VJ, Santa-Ana-Tellez Y, Korenromp EL (2011) Unit costs for delivery of antiretroviral treatment and prevention of mother-to-child transmission of HIV: a systematic review for low- and middle-income countries. Pharmacoeconomics 29(7): 579-599. doi: 10.2165/11586120-000000000- 00000.
President's Emergency Plan for AIDS Relief (2013) 2013 Report on Costs of Treatment in the President's Emergency Plan for AIDS Relief (PEPFAR). PEPFAR. Available: http://www.pepfar.gov/documents/organization/212059. pdf. Accessed 2014 Oct 25.
UNAIDS (2004) Access to HIV Treatment and Care. Fact Sheet. UNAIDS. Available: http://data.unaids.org/publications/fact-sheets04/fs-treatment-en. pdf. Accessed 2014 Oct 25.
Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: A systematic review and meta-analysis
Suthar AB, Granich R, Mermin J, Van Rie A (2012) Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis. Bulletin of the World Health Organization 2012. 90: 128-138C. doi:10.2471/BLT.11.093260.